Study: Anti-CD20 Therapies, Gilenya Lower Efficacy of COVID-19 Vaccines
Certain treatments for multiple sclerosis (MS) — specifically, anti-CD20 antibody therapies and Gilenya (fingolimod) — are likely to reduce the effectiveness of vaccines…
COVID-19 Vaccine Reactions in People with MS Similar to General Population, Says New Society-Funded Study
November 17, 2021 Surveys of hundreds of people with MS enrolled in the iConquerMS network reveal that reactions to COVID-19…
Stuart Schlossman
Smoking, Most DMTs Not Associated With Severe COVID-19 in Patients With MS
December 11, 2021 by Skylar Jeremias Although obesity, diabetes, and certain comorbidities were all detected as risk factors…
Stuart Schlossman
mRNA COVID-19 vaccines effective in patients with MS on disease-modifying therapies
December 3, 2021 Messenger RNA COVID-19 vaccination was effective among most patients with MS who used various disease-modifying therapies, according…
Stuart Schlossman
Timing of rituximab infusion not tied to risk for COVID-19 hospitalization
December 6, 2021 The timing of rituximab infusion or cumulative lifetime rituximab dose did not appear statistically significantly associated with…
Stuart Schlossman
Rituximab, ocrelizumab pose risks in patients with MS and COVID-19
October 07, 2021 Rituximab and ocrelizumab appeared to increase risk for adverse outcomes among patients with MS and COVID-19, according…
Stuart Schlossman
Black People Undergoing MS Treatment Can Benefit From COVID Vaccines
New research may be a determining factor for Black multiple sclerosis (MS), who often experience different symptoms than those of…
Stuart Schlossman
Severe COVID-19 may trigger autoimmune conditions; New variants cause more virus in the air
by Nancy Lapid Sept 22 (Reuters) – The following is a summary of some recent studies on COVID-19. They include…
Stuart Schlossman
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab
September 23, 2021 Livnat Brill, PhD1; Ariel Rechtman, BSc1; Omri Zveik, BMedSc1; et al Nitzan Haham, BMedSc1; Esther Oiknine-Djian, PhD2,3; Dana G. Wolf, MD, PhD2,3; Netta Levin, MD, PhD1; Catarina Raposo, PhD4; Adi Vaknin-Dembinsky, MD, PhD1 Author Affiliations Article Information JAMA Neurol. Published online September 23, 2021. doi:10.1001/jamaneurol.2021.3599…
Stuart Schlossman
‘Shining a light on MS learnings from the COVID-19 pandemic’ – a PRISMS webinar
The first webinar will take place on September 23, 2021 at 2:30pm EDT until 3:30pmET Registrations are open at https://www.prismswebinar.online/user/register. The event…
Stuart Schlossman
